TipRanks
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1

Compare Vertex Pharmaceuticals (VX1) vs. Competitors

23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€475.00
€114.02B
29.07
29.78%
21 Buy
3 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$29.40B
36.05
-51.82%
18 Buy
4 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.07B
151.42
3.81%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.85B
-12.15
-22.75%
4 Buy
9 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.72B
-3.79
-36.12%
6 Buy
5 Hold
3 Sell
Hold
Crispr Therapeutics AG
$60.90
$5.36B
-12.05
-15.35%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
448.60
104.95
30.54%
ALNY
Alnylam Pharma
219.89
-232.11
-51.35%
BMRN
BioMarin Pharmaceutical
57.54
1.93
3.47%
SRPT
Sarepta Therapeutics
17.49
-5.77
-24.81%
NTLA
Intellia Therapeutics
12.75
-7.79
-37.93%
CRSP
Crispr Therapeutics AG
57.34
-12.85
-18.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts